| 1 |
33631357 | RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. | 2021 Apr |
1 |
| 2 |
33782036 | Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial. | 2021 Apr 7 |
1 |
| 3 |
34214315 | Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya). | 2021 Jun 25 |
1 |
| 4 |
34412518 | Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review. | 2021 Nov |
1 |
| 5 |
31964342 | Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study. | 2020 Jan 21 |
1 |
| 6 |
31995035 | Anthracycline-induced cardiotoxicity prevention with angiotensin-converting enzyme inhibitor ramipril in women with low-risk breast cancer: results of a prospective randomized study. | 2020 Feb 25 |
1 |
| 7 |
32419571 | Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice. | 2020 Apr-Jun |
1 |
| 8 |
30075570 | Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: A case report. | 2018 Aug |
1 |
| 9 |
27885499 | The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study. | 2017 Jun |
1 |
| 10 |
28155333 | Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies. | 2017 Aug |
1 |
| 11 |
25511130 | Highly regio- and enantioselective synthesis of γ,δ-unsaturated amido esters by catalytic hydrogenation of conjugated enamides. | 2015 Feb 2 |
1 |
| 12 |
25680080 | The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. | 2015 Apr 15 |
1 |
| 13 |
25796267 | A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). | 2015 Aug |
1 |
| 14 |
25878372 | A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy. | 2015 Mar-Apr |
2 |
| 15 |
25973747 | High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin. | 2015 |
1 |
| 16 |
25980448 | A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. | 2015 Oct |
2 |
| 17 |
26400542 | MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury. | 2015 Dec 1 |
1 |
| 18 |
28352720 | Trends in the treatment of risk factors for stroke in a Czech stroke unit. | 2015 |
1 |
| 19 |
25256070 | Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts. | 2014 Dec |
1 |
| 20 |
25325125 | Treating essential hypertension. The first choice is usually a thiazide diuretic. | 2014 Sep |
1 |
| 21 |
25391139 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). | 2014 Nov 12 |
1 |
| 22 |
25702405 | [Azilsartan--new representative of the class of angiotensin receptor blockers II]. | 2014 |
1 |
| 23 |
23419082 | Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information. | 2013 Aug |
2 |
| 24 |
23466153 | [Telangiectasia during amlodipine therapy]. | 2013 Mar |
1 |
| 25 |
23747952 | Ramipril-induced liver injury: case report and review of the literature. | 2013 Sep |
2 |
| 26 |
23819631 | EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy--rationale and design of the EARLY hypertension registry. | 2013 Jul 2 |
1 |
| 27 |
23867841 | Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460. | 2013 Aug |
2 |
| 28 |
23933903 | Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. | 2013 Jul |
2 |
| 29 |
24267241 | Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication. | 2013 Dec |
1 |
| 30 |
24285767 | Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease. | 2013 Nov |
1 |
| 31 |
24308214 | Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension. | 2013 Sep |
2 |
| 32 |
20970202 | Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). | 2012 Feb 9 |
3 |
| 33 |
22776970 | The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. | 2012 |
4 |
| 34 |
22811928 | Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients. | 2012 |
1 |
| 35 |
23430666 | Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis. | 2012 Dec |
1 |
| 36 |
20930708 | Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. | 2011 Apr |
1 |
| 37 |
20980201 | Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. | 2011 Jan |
2 |
| 38 |
21496825 | Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting enzyme inhibitors. | 2011 May 20 |
1 |
| 39 |
21780334 | Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease. | 2011 Jun |
1 |
| 40 |
21881539 | Ramipril modulates circadian gene expression in skeletal muscle. | 2011 Nov |
1 |
| 41 |
22746010 | [Primary and secondary prevention of ischemic stroke]. | 2011 Oct-Dec |
1 |
| 42 |
19697290 | [Relation between defined daily doses (DDD) and prescribed daily doses: a 3-month analysis of outpatient data from a statutory health insurance company]. | 2010 Jul |
1 |
| 43 |
19875309 | Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. | 2010 Apr |
3 |
| 44 |
20102972 | Telmisartan in high-risk cardiovascular patients. | 2010 Jan 4 |
1 |
| 45 |
20491360 | Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend. | 2010 Mar-Apr |
2 |
| 46 |
20517677 | Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction. | 2010 May |
1 |
| 47 |
20859899 | Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone. | 2010 Sep |
1 |
| 48 |
21051889 | From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors. | 2010 |
1 |
| 49 |
21154353 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). | 2010 Dec 8 |
1 |
| 50 |
19118720 | Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients. | 2009 Jan 6 |
1 |